Healthcare Value Capital

Healthcare Value Capital as of Sept. 30, 2020

Portfolio Holdings for Healthcare Value Capital

Healthcare Value Capital holds 17 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Glaxosmithkline Sponsored Adr 12.4 $3.8M 100k 37.64
Jazz Pharmaceuticals Shs Usd (JAZZ) 11.7 $3.6M 25k 142.60
Gilead Sciences (GILD) 10.4 $3.2M 50k 63.20
Abbvie (ABBV) 10.1 $3.1M 35k 87.60
Proshares Tr Ultrapro Short S 10.0 $3.0M 350k 8.70
Vyne Therapeutics Com New 9.8 $3.0M 1.8M 1.66
Tyme Technologies 7.0 $2.1M 2.2M 0.98
McKesson Corporation (MCK) 4.9 $1.5M 10k 148.90
Clovis Oncology 4.8 $1.5M 250k 5.83
Antares Pharma 4.4 $1.4M 500k 2.70
Cardinal Health (CAH) 3.9 $1.2M 25k 46.96
Moderna Put Option (MRNA) 2.3 $708k 10k 70.80
Greenlane Hldgs Cl A 1.8 $560k 250k 2.24
Novavax Com New Put Option (NVAX) 1.8 $542k 5.0k 108.40
Proshares Tr Ii Vix Sh Trm Futrs Call Option 1.7 $510k 25k 20.40
Amarin Corp Spons Adr New Call Option (AMRN) 1.4 $421k 100k 4.21
Adamas Pharmaceuticals 1.4 $412k 100k 4.12